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INTRODUCTION 
 
As more products enter the market each year with claims around immune 
modulation and anti-inflammatory effects, livestock producers and nutritionists are being 
challenged to become conversant in yet another specialty. This paper will focus on the 
underlying changes in immune function that are apparent in transition dairy cattle, how 
inflammatory signaling is involved, and what we know about how and if we should 
attempt to alter this phenomenon. 
 
WHY WORRY ABOUT IMMUNITY? 
 
Large-scale analysis of dairy herd records suggests that, around the globe, 
transition cow problems account for over half of mature animal health problems on a 
typical dairy farm. There are some obvious risks to cows immediately after calving, 
including the potential for latent mastitis cases to re-emerge at the onset of lactation and 
the tissue trauma from calving. However, there is also a well-documented alteration in 
immune function during the weeks around calving (Kerhli, 2015). In particular, the function 
of innate immune cells seems to be consistently impaired. Innate immune cells are those 
involved in quick recognition and clearance of pathogens, independent of pathogen-
specific memory (antibodies). 
 
Why is the immune system of transition cows suppressed? The exact reasons for 
decreased immune function during the transition period are complex. However, studies 
with mastectomized cows suggest that the primary driver is not gestation and calving, but 
rather lactation and the metabolic changes that come with it (Nonnecke et al., 2003). 
Numerous large studies have demonstrated that metabolic diseases (e.g. ketosis) put 
cows at higher risk of contracting clinical infections; likewise, cows with infectious 
diseases (e.g. metritis) are also at higher risk of subsequent metabolic disorders. The 
inter-dependent nature of the immune and metabolic systems in the animal are only now 
becoming clear, but high blood ketone and non-esterified fatty acid concentrations as well 
as hypocalcemia are known to limit the responsiveness of immune cells to pathogenic 
signals. Cows with excessive body condition experience more dramatic drops in immune 
function at calving, possibly as a consequence of oxidative stress. As a result, nutrition of 
the transition cow can have a large influence on immunity during this time, even beyond 
the vitamins and minerals that have received focus in the past. 
 
There is some direct evidence that poor immune responsiveness in the transition 
period is predictive for incidence of infections during this time. In one study, 5 of 31 cows 
were identified as poor immune responders 4 weeks before calving. All 5 of these cows 
developed clinical infections during the first 2 months of lactation, whereas only 3 of the 
other 26 cows did so (Catalani et al., 2013). A much larger study of 458 Holstein cows 
demonstrated that a measure of antibody-mediated immunity was highly predictive of 
mastitis incidence, with the top quintile showing a 42% lower mastitis incidence than 
herdmates (Thompson-Crispi et al., 2013). It is likely that the high rate of infections in 
early lactation can be attributed in part to immunosuppression. 
 
WHAT DOES INFLAMMATION HAVE TO DO WITH TRANSITION COWS? 
 
Inflammation is a key component of the immune response to infection or tissue 
damage. Immune cells that first sense pathogens or signs of traumatized cells release 
signals that activate pain sensors, promote blood flow to the local tissue, and cause fever, 
accounting for the traditional signs of inflammation. Additionally, the systemic effects of 
inflammation include an alteration of liver function, typically called the acute phase 
response. Most of these responses are beneficial for recruiting innate immune cells to the 
site of immune activation and for inhibition of bacterial growth, but they come at a cost to 
the animal. Importantly, inflammation can occur in the absence of a true pathogen 
challenge and can occur without the traditional signs of focal pain, swelling, and redness. 
When blood markers of inflammation are elevated in the absence of clinical signs, it is 
often referred to as sub-acute inflammation. 
 
The presence of an acute phase response in postpartum dairy cows is well-
established (Bradford et al., 2015). Although early studies focused on associations 
between inflammatory markers and diseases such as mastitis and metritis, numerous 
studies in the past decade have demonstrated that inflammatory and acute-phase 
mediators are elevated in the days after parturition, even in cows that are apparently 
healthy. This growing body of evidence suggests that either the processes of parturition 
and galactopoiesis induce inflammation directly or that infections or endotoxin affect far 
more fresh cows than is currently recognized. Whatever the explanation, the prevalence 
of post-calving inflammation raises important questions about the implications for early 
lactation cows. 
 
Although most transition dairy cows apparently experience a period of 
inflammation, the magnitude of this inflammatory condition varies greatly between cows. 
Bertoni et al. (2008) assessed the importance of this variation by measuring a panel of 
inflammatory markers and separating transition cows into quartiles for degree of 
inflammation. Cows in the highest quartile had significantly lower milk yields than those 
in the lowest quartile throughout the first month of lactation, differing by 20% on day 28 
of lactation (Bertoni et al., 2008). One metric that has been used in this respect is 
paraoxonase, a plasma biomarker that is potently suppressed by a variety of inflammatory 
stimuli. Transition cows with high paraoxonase concentrations, in addition to having lower 
concentrations of acute phase proteins and reactive oxygen metabolites, produced 4,346 
lb more milk (24%) over 305 days than those in the lowest quartile for paraoxonase 
(Bionaz et al., 2007). Other findings suggest that stronger inflammatory responses in the 
first week of lactation are associated with decreased whole-lactation milk yield (Huzzey 
et al., 2015). Plasma concentrations of haptoglobin (an acute phase protein) greater than 
1.1 g/L were associated with a 2,088 lb decrease in 305-day mature equivalent milk yield, 
and elevated haptoglobin was also associated with a 19% decreased risk of conception. 
Abnormally high markers of inflammation are associated with poor production, health, and 
fertility outcomes. 
 
IMMUNE PROMOTION TOOLS 
 
With the growing interest in animal characteristics influencing infection risk, a 
number of factors have emerged as important for supporting strong immunity. Data 
currently available suggest that cows have improved transition immune function when: 1) 
they are not exposed to significant heat stress during the dry period (do Amaral et al., 
2011); 2) they calve with a BCS between 2.5 and 3.5 (Graugnard et al., 2012; Esposito 
et al., 2014; Crookenden et al., 2017); 3) they are supplemented with antioxidants during 
the dry period (Spears and Weiss, 2008); 4) total serum total calcium concentrations are 
maintained near 9 mg/dL (Martinez et al., 2012; Martinez et al., 2014), and 5) blood BHBA 
and NEFA concentrations stay below 1 mM during the transition (Grinberg et al., 2008; 
Contreras and Sordillo, 2011; McArt et al., 2013). Considering the immune system of the 
transition cow does not necessarily require a change in recommendations for 
management during this period, but can provide additional motivation to prevent heat 
stress, provide sufficient access to feed, manage body condition, support calcium 
homeostasis, and monitor oxidative balance. 
 
Beyond these best practices for transition cow management, a variety of dietary 
and pharmaceutical products are being marketed for the explicit purpose of improving 
immune function. Vaccines have obviously been a very useful tool in promotion of 
adaptive immunity for decades, and the ongoing development of a vaccine against 
metritis-causing pathogens may soon bring a new weapon to bear on a frustrating 
problem (Machado et al., 2014). On the other hand, pharmacological tools for promotion 
of innate immunity have not been available for livestock until very recently. Granulocyte 
colony-stimulating factor (GCSF) is a signal used by the immune system which has been 
adapted into an injectable prophylactic treatment used prior to the period of 
immunosuppression. The GCSF treatment stimulates the development and maturation of 
neutrophils, resulting in a fairly dramatic increase in the population of these key innate 
immune cells in circulation. In conditions favorable to environmental mastitis, the 
administration of GCSF significantly decreases the incidence of clinical mastitis 
(Hassfurther et al., 2015). 
 
Dietary agents are also being used as immune modulators, although the exact 
modes of action for these feed additives are more elusive. We recently reported that a 
dietary yeast product enhanced antibody response to vaccination and stimulated greater 
gut release of IgA, which is able to bind to and carry pathogens out of the gut (Yuan et 
al., 2015). A large-scale analysis of commercial farm responses (off-on) to a different feed 
supplement was presented recently, suggesting beneficial effects on farm-recorded 
mastitis and mortality (Chapman et al., 2016). Such dietary components can likely alter 
the responsiveness of the immune system by interacting with immune sentinels lining the 
gut and/or by altering gut epithelium function, but other mechanisms cannot yet be ruled 
out. 
 
RESPONSES TO ANTI-INFLAMMATORY TREATMENTS 
 
Motivated by evidence linking early lactation inflammation to decreased health and 
productivity, we conducted a study with 78 cows assigned to either control or sodium 
salicylate delivered via drinking water (2 g/L) for the first 7 days of lactation (Farney et al., 
2013). Sodium salicylate is a member of the non-steroidal anti-inflammatory drug (NSAID) 
class, and is the parent compound of aspirin. At first the results did not look very 
promising, with no improvement in metabolic health and no increase in early milk yield. 
However, as lactation progressed, the oldest cohort of cows treated with salicylate (those 
in parity 3 and greater) responded by producing 21% more milk over the full lactation, and 
fully 30% more milk fat, than parity-matched controls. On the other hand, primiparous 
cows treated with salicylate tended to produce less milk, suggesting a potential parity 
difference in either baseline inflammatory status or response to inflammatory signals. 
 
We subsequently completed a follow-up study to evaluate whether postpartum 
treatment of multiparous cows could increase whole-lactation productivity of cows on a 
commercial farm. To facilitate treatment in a commercial setting, we shortened 
postpartum treatment to 3 days (sodium salicylate) or 1 day (meloxicam) and compared 
them to placebo treatments (Carpenter et al., 2016a) across 153 cows. Despite this very 
limited treatment window, cows treated with either NSAID produced about 10% more milk 
over the whole lactation compared to placebo. Over the 365 days following treatment, 
meloxicam also tended to delay removal from the herd based on survival analysis (P = 
0.06; 30, 35, and 38 of 51 cows remained at 365 d postpartum for control, salicylate, and 
meloxicam, respectively). Meloxicam primarily affected early-lactation culling, and health 
records recorded by the farm suggested that metabolic disorders accounted for most of 
this decrease.  
 
Several other groups in a variety of countries have failed to observe significant 
impacts of postpartum anti-inflammatory treatment on milk yield, and it remains to be seen 
whether a treatment paradigm can be found that is consistently effective. However, we 
believe that impacts on long-term milk yield likely require treatment relatively early after 
calving (though not before the placenta is cleared); that treatment responsiveness is not 
limited to cows with calving difficulties; and that milk yield must be monitored for at least 
60 days into lactation to have a good chance to observe the impact of anti-inflammatory 
treatment. 
 
The use of anti-inflammatory drugs to treat nonspecific postpartum inflammation is 
not currently approved. Therefore, it is worthwhile to consider whether some feed 
ingredients might offer the same anti-inflammatory benefits without the use of regulated 
pharmaceuticals.  
 
Polyphenols are a diverse class of compounds found in nearly all plants in varying 
concentrations. Some polyphenols have been clearly shown to have potent anti-
inflammatory effects, and a recent study demonstrated some exciting responses in dairy 
cattle during the transition period. Winkler et al. (2015) supplemented cows with a feed 
supplement containing green tea and curcuma extract (both potent sources of 
polyphenols) for the close-up period through 9 weeks in milk. In addition to decreasing 
liver lipids, supplementation decreased plasma NEFA concentrations after calving and 
increased milk yield by approximately 10 lb/day in weeks 4 – 8 of lactation. It is not entirely 
clear that these production responses were due to anti-inflammatory effects of the 
polyphenols, but they certainly warrant further study. 
 
A different nutritional approach to limiting inflammation is to use omega-3 fatty 
acids. These polyunsaturated fatty acids have well-described mechanisms underlying 
their anti-inflammatory effects, although efficiently delivering them to the small intestine 
is a challenge in ruminants because of ruminal biohydrogenation of dietary unsaturated 
fatty acids. Nevertheless, feeding whole flaxseed (omega-3 source) compared to sources 
of omega-6 fatty acids increased plasma glucose and decreased plasma ketones in fresh 
cows; more surprisingly, the anti-inflammatory omega-3 source resulted in greater 
phagocytic activity of circulating leukocytes (Gandra et al., 2016). Although this finding of 
improved metabolic and immune function is exciting, previous studies have reported 
indications of less responsive immune systems in cows fed omega-3 sources (Lessard et 
al., 2003; Silvestre et al., 2011), and such findings are more in line with research in 
rodents. Perhaps the key to beneficial impacts of omega-3 fatty acids on both 
inflammation and immunity is an improvement in metabolic profile. 
 
IS THERE AN INHERENT CONFLICT BETWEEN PROMOTING IMMUNITY AND 
PREVENTING EXCESSIVE INFLAMMATION? 
 
Because inflammation is a core component of the immune system’s response to 
an infection, it is logical to ask whether anti-inflammatory strategies may worsen the 
immunosuppression that is already recognized as a problem in transition cows. In fact, 
Nightingale et al. (2015) demonstrated that transition cows with the most dramatic 
inflammatory profiles also had the most potent measures of neutrophil function. One 
interpretation of these findings is that transition cows are adapted to respond to 
immunosuppression with a compensatory inflammatory state. 
 
Inherent conflicts between anti-inflammatory strategies and potent immune 
responses are also suggested by findings of increased infection rates following NSAID 
treatments in some small studies and greater mortality rates following pathogen 
challenges in mice genetically engineered to allow for endogenous omega-3 synthesis 
(Bradford et al., 2015). Likewise, dietary supplementation of an immune modulator 
resulted in an increased acute phase response to endotoxin (Brandão et a., 2016), 
suggesting that at least some means of enhancing immunity will likely promote 
inflammation as well, although conversely, the febrile response was lessened. In support 
of the concept that a more appropriate balance between immunity and inflammation can 
be achieved, the immune stimulant described above resulted in increased milk yield 
(Brandão et a., 2016), and as mentioned before, post-calving meloxicam treatment 
increased both milk yield and herd retention (Carpenter et al., 2016a). 
 
One question that has not yet been addressed in observational studies is whether 
the pattern of inflammation impacts long-term outcomes. We hypothesize that brief spikes 
in inflammatory signals that are resolved in the first 3-4 days of lactation may support 
immunity and physiological adaptations to lactation. However, failure to rapidly resolve 
these signals may lead to a variety of adverse impacts that ultimately impair productivity, 
health, and fertility (Figure 1). We hope that new data will begin to address this question 
in the coming few years. 
  
Figure 1. Hypothetical impacts of brief, rapidly resolved postpartum inflammation versus 
sustained inflammation. It is proposed that lack of resolution leads to impaired 
health and productivity rather than the inflammation per se. 
 
 
 
 
CHOOSING THE RIGHT STRATEGY FOR EACH HERD 
 
In research with anti-inflammatory agents, there have been some marked 
differences across studies that, while not allowing strong conclusions, hint at predictors 
for success with these tools. First, treatment with Banamine shortly before and shortly 
after calving disrupted the normal process of calving and placental expulsion (Newby et 
al. 2017), resulting in increased incidence of stillbirths (if given before calving) and metritis 
(if given after calving). This particular approach to combatting calving-associated pain and 
inflammation is not advised until at least 24 hours after calving. On the other hand, similar 
strategies with a different NSAID, meloxicam, did not trigger the same negative effects 
(Newby et al., 2014). 
 
Second, we have seen variable milk production responses to NSAID treatment 
even when using identical strategies. Treatment with sodium salicylate for 3 days starting 
24 hours after calving increased whole-lactation milk yield by more than 2,000 pounds in 
one study (Carpenter et al., 2016a), whereas in a follow-up study, we observed no milk 
response at all (Carpenter et al., 2016b). One potentially relevant difference between the 
cohorts in these two studies is that the responsive group had substantially greater post-
calving inflammation, as the mean plasma haptoglobin concentration was more than twice 
as high in the responsive group compared to the unresponsive group on days 3-4 of 
lactation. Although we have been unable to demonstrate that individual cows with higher 
haptoglobin concentrations are more responsive to NSAID treatment, differences 
between these two studies seem to point in that direction. 
 
Finally, it stands to reason that farms with more infectious disease problems are 
likely to have more obvious benefits from immune stimulation. As a simple example, on-
farm evaluation of responses to a dietary immune modulator showed that decreases in 
somatic cell count after supplementation began were greatest in herds that started with 
relatively high somatic cells (Chapman et al., 2016).  
 
Although there is little research basis for this suggestion, mechanisms connecting 
inflammation and immunity lead to the suggestion that cows in different herds may 
struggle with different mixtures of transition disorders because of imbalances between 
pro- and anti-inflammatory signals; excessive inflammation in some herds and inadequate 
immunity in others. Based on this logic, herds that have relatively high prevalence of 
infectious diseases in early lactation might be wise to focus on trying immune support 
tools in an attempt to enhance cows’ abilities to combat pathogens. Conversely, herds 
with more metabolic disorders in early lactation should consider implementing anti-
inflammatory management and nutritional strategies. Combinations of both types of 
supplements may or may not have additive benefits - these interactions simply have not 
been studied.  
 
SUMMARY 
 
The growing number of tools available to aid cows successfully transition to 
lactation is exciting, but, as always, the devil is in the details. Several pharmaceutical and 
feed additive strategies have strong evidence for specific benefits, but individual farms 
differ in important ways that can lead to unique questions about secondary effects that 
are less clear. In particular, unresolved questions about tradeoffs between inflammatory 
status and immunity make it difficult to give one-size-fits-all recommendations when the 
transition problems encountered on one farm can differ so dramatically from another. 
Based on evidence available today, farms with more frequent infectious disease problems 
are encouraged to explore opportunities to promote immune function, whereas those with 
prevalent metabolic disorders should perhaps focus more on anti-inflammatory 
strategies. Research on combinations of such strategies is needed before 
recommendations can be provided with confidence. 
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